| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.29 | 0.06 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.21 | 0.005 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.02 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.16 | 0.3 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | -0.15 | 0.01 |